1. Home
  2. SNGX vs GURE Comparison

SNGX vs GURE Comparison

Compare SNGX & GURE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNGX
  • GURE
  • Stock Information
  • Founded
  • SNGX 1987
  • GURE 2006
  • Country
  • SNGX United States
  • GURE China
  • Employees
  • SNGX N/A
  • GURE N/A
  • Industry
  • SNGX Biotechnology: Pharmaceutical Preparations
  • GURE Major Chemicals
  • Sector
  • SNGX Health Care
  • GURE Industrials
  • Exchange
  • SNGX Nasdaq
  • GURE Nasdaq
  • Market Cap
  • SNGX 9.6M
  • GURE 7.9M
  • IPO Year
  • SNGX 1987
  • GURE 1992
  • Fundamental
  • Price
  • SNGX $3.51
  • GURE $0.65
  • Analyst Decision
  • SNGX
  • GURE
  • Analyst Count
  • SNGX 0
  • GURE 0
  • Target Price
  • SNGX N/A
  • GURE N/A
  • AVG Volume (30 Days)
  • SNGX 56.4K
  • GURE 190.4K
  • Earning Date
  • SNGX 11-08-2024
  • GURE 11-26-2024
  • Dividend Yield
  • SNGX N/A
  • GURE N/A
  • EPS Growth
  • SNGX N/A
  • GURE N/A
  • EPS
  • SNGX N/A
  • GURE N/A
  • Revenue
  • SNGX $364,183.00
  • GURE $16,426,231.00
  • Revenue This Year
  • SNGX N/A
  • GURE N/A
  • Revenue Next Year
  • SNGX $76.64
  • GURE N/A
  • P/E Ratio
  • SNGX N/A
  • GURE N/A
  • Revenue Growth
  • SNGX N/A
  • GURE N/A
  • 52 Week Low
  • SNGX $1.83
  • GURE $0.51
  • 52 Week High
  • SNGX $32.00
  • GURE $1.79
  • Technical
  • Relative Strength Index (RSI)
  • SNGX 49.14
  • GURE 40.73
  • Support Level
  • SNGX $3.50
  • GURE $0.61
  • Resistance Level
  • SNGX $3.74
  • GURE $0.69
  • Average True Range (ATR)
  • SNGX 0.20
  • GURE 0.09
  • MACD
  • SNGX 0.01
  • GURE 0.01
  • Stochastic Oscillator
  • SNGX 47.37
  • GURE 60.87

About SNGX Soligenix Inc.

Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19).

About GURE Gulf Resources Inc. (NV)

Gulf Resources Inc is a holding company engaged in the manufacture and trade of bromine and crude salt, and natural gas; manufactures and sells chemical products used in oil and gas field exploration, oil and gas distribution, oil field drilling, wastewater processing, papermaking chemical agents and inorganic chemicals, and manufactures and sells materials for human and animal antibiotics. It operates in four segments: Bromine, Crude Salt, Chemical Products and Natural Gas. It derives maximum revenue from the Bromine segment which is commonly used in brominated flame retardants, fumigants, water purification compounds, dyes, medicines and disinfectants.

Share on Social Networks: